X39 Studies
1
This study used non-invasive brain mapping to assess the effects of LifeWave X39 patches on brain function in 10 participants. Results showed significant improvements in brain energy levels and overall cognitive function. The patches enhanced brain activity and energy, supporting their use for cognitive health.
2
This study assessed the effects of the LifeWave X39 patch on 50 participants aged 40-81 over seven days. Significant improvements were found in short-term memory, sleep quality, vitality, and blood pressure. The patch also increased levels of eight amino acids, suggesting enhanced metabolism and neurotransmitter production.
3
This study explored the metabolic effects of the LifeWave X39 patch on 15 subjects over one week. Significant improvements were observed in sleep quality, short-term memory, and vitality. Blood pressure improved, and 17 amino acids showed statistically significant changes, indicating enhanced metabolic function and overall well-being.
4
This study evaluated the metabolic effects of the LifeWave X39 patch on 50 participants. Significant improvements were found in neurotransmitter levels, sleep quality, and overall energy. The patch effectively enhanced metabolic function, supporting its use for improving physiological health.
5
This pilot study of 15 participants aged 40-65 found that wearing the LifeWave X39 patch for one week significantly improved sleep quality, reduced blood pressure, and enhanced short-term memory. The study also showed significant changes in essential and non-essential amino acids, suggesting the patch supports metabolic and physiological health.
6
From this research, we can conclude that LifeWave, Inc. X-39 patch is effective in elevating the overall energetic vitality of the biofield and the body and also boosting the self-healing mechanisms. This study reveals the potential of X-39 patches to provide sustainable non-drug therapy. Several anecdotal responses were heard from the subjects that the patches helped them to have an active day and sound sleep in the night.
7
This double-blind, randomized controlled trial studied 60 participants aged 40-80. The LifeWave X39 patch significantly increased GHK-Cu levels in the blood from Day 2 to Day 7, with p-values of 0.035 for GHK-Cu concentration and 0.03 for total GHK-Cu. The study confirms the patch's efficacy in boosting GHK-Cu levels​​.
8
This pilot study examined the LifeWave X39 patch's impact on blood levels of GHK and GHK-Cu in 10 participants. Significant increases in GHK were observed at 24 hours and GHK-Cu at 7 days, indicating the patch effectively enhances the production of these beneficial peptides​​.
9
This study tested the effects of the LifeWave X39 patch on blood levels of GHK and GHK-Cu in 10 subjects aged 40-81. Results showed a significant increase in GHK levels after 24 hours and GHK-Cu levels after 7 days, suggesting the patch promotes beneficial physiological changes​​.
10
This study investigated the changes in the levels of GHK-CU in the blood resulting from wearing the LifeWave X39 patch for one week in individuals aged 40 to 80. A significant increase in GHK-CU concentration was observed in the active group. The p-values for comparing changes from Day 1 to Day 2, Day 1 to Day 7, and Day 2 to Day 7 between Group A and Group B were significant. Specifically, the GHK-CU concentration (ng/ml) had a p-value of less than 0.035, and the total GHK-CU (ng) had a p-value of less than 0.03.